Clinical trial for Hematopoietic and Lymphatic System Neoplasm
Official title Web-Based Toolkit to Improve Cancer-Related Emotional Distress and Anxiety in Rural Older Cancer Survivors
ClinicalTrials.gov ID: NCT07290543
What this study is testing
- What it's testing
- This study is testing whether the CONNECT web toolkit can reduce cancer‑related emotional distress. It also looks at anxiety in older adults in rural areas.
- Who it's for
- You may join if you are an older adult with cancer in a rural area and feel distress.
- What's involved
- You will use the CONNECT online tool on a computer or tablet. It will help you set up telehealth visits, read education material, and get mental‑health resource suggestions.
- Time commitment
- The study lasts several weeks with a few online sessions and check‑ins.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- AIM 1: Invited by a member of the study team
- Healthcare professionals (physicians, nurses, pharmacists, etc.)
- Patient advocates and representatives
- Researchers in healthcare or technology fields
- Healthcare administrators and managers
You likely can't join if
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Experience a cancer recurrence or a new cancer diagnosis during their participation in the trial because of the...
- AIM 2 (RURAL OLDER CANCER SURVIVORS AND CAREGIVER): Are inpatients
- AIM 2 (RURAL OLDER CANCER SURVIVORS AND CAREGIVER): Cognitive impairment precludes the ability to provide written consent
See the full eligibility criteria
- AIM 1: Invited by a member of the study team
- Healthcare professionals (physicians, nurses, pharmacists, etc.)
- Patient advocates and representatives
- Researchers in healthcare or technology fields
- Healthcare administrators and managers
- AIM 1: Must be over 18 years old
- AIM 1: English-speaking
- AIM 1: Willing and able to provide informed consent
- AIM 2 (RURAL OLDER CANCER SURVIVORS): A rural resident based on the Health Resources \& Services Administration (HRSA) rural analyzer
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Self-report of diagnosis with any cancer
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Self-report posttreatment (i.e., completion of curative intent therapy including surgery, chemotherapy, molecularly targeted, and endocrine therapy)
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Have access to a computer, a smartphone, or a tablet computer
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Aged \> 65 years old
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Assessed as having Cancer and Treatment Distress scale (CTXD) scores \> 0.85 at screening
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Have a caregiver willing to participate
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Non-institutionalized
- AIM 2 (RURAL OLDER CANCER SURVIVORS): English proficient
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Willing and able to provide informed consent
- AIM 2 (CAREGIVER): An identified informal caregiver of an eligible ROCS (caregivers include, but are not limited to, a child, partner, or friend
- AIM 2 (CAREGIVER): Have internet access
- AIM 2 (CAREGIVER): ≥ 18 years old
- AIM 2 (CAREGIVER): Non-institutionalized
- AIM 2 (CAREGIVER): English proficient
- AIM 2 (CAREGIVER): Willing and able to provide informed consent
- AIM 3 (FINAL WORKSHOP): Includes providers, medical and practice managers, patient care coordinators, and medical health technologists
- AIM 2 (RURAL OLDER CANCER SURVIVORS): Experience a cancer recurrence or a new cancer diagnosis during their participation in the trial because of the body of literature that reports increased distress associated with...
- AIM 2 (RURAL OLDER CANCER SURVIVORS AND CAREGIVER): Are inpatients
- AIM 2 (RURAL OLDER CANCER SURVIVORS AND CAREGIVER): Cognitive impairment precludes the ability to provide written consent
The study team makes the final eligibility decision.
Where it is enrolling
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Chicago, Illinois, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.